Acetylcholinesterase (AChE) is an enzyme that hydrolyzes acetylcholine in the nervous system [1], and it is a target enzyme for drug development in neurodegenerative disease, including Alzheimer’s disease (AD) [2]. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.